Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
Namrata S. Patil, Barzin Y. Nabet, Sören Müller, Hartmut Koeppen, Wei Zou, Jennifer M. Giltnane, Amelia Au‐Yeung, Shyam Srivats, Jason Cheng, Chikara Takahashi, Patrícia E. de Almeida, Avantika S. Chitre, Jane L. Grogan, Linda Rangell, Sangeeta Jayakar, Maureen Peterson, Allison W. Hsia, William O’Gorman, Marcus Ballinger, Romain Banchereau, David S. Shames
Topics & Concepts
AtezolizumabBlockadeLung cancerCD8Cancer researchPD-L1CellT cellChemotherapyMedicineOncologyTranscriptomeCancerInternal medicineImmunotherapyBiologyImmunologyGeneReceptorImmune systemGene expressionNivolumabGeneticsBiochemistryCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionCAR-T cell therapy research